CA46975-7A - 0x0000000000006E30

Healthy Males & Females

Refresh

* Stipend may pay up to reflected amount.
Start Date: 
May 30, 2026 - 2:00pm
End Date: 
June 15, 2026 - 8:30am

Study Details

Study Number: CA46975
Group Number: 7A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,500.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat of atopic dermatitis (AD).
Route of Administration: Oral
Blood Draws: 20

Study Schedule

Schedule Type: Long Term
Study Length: 9 Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Wednesday 5/20/2026
Tuesday 5/26/2026
Friday 5/29/2026
Saturday 5/30/2026

Doctor Exam Dates:

Event Day Event Date
Wednesday 5/20/2026
Tuesday 5/26/2026
Friday 5/29/2026
Saturday 5/30/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday 5/30/2026 2:00:00 PM Monday 6/8/2026 8:45:00 AM 1 Lincoln
Return Monday 6/15/2026 7:30:00 AM Monday 6/15/2026 8:30:00 AM 1 Lincoln